Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Triple Negative Breast Neoplasms 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1

Interventions

Radiotherapy 4Surveys and Questionnaires 3Paclitaxel 3Metformin 2Gemcitabine 2Cisplatin 2sintilimab 1fluoromisonidazole 1X-Rays 1Watchful Waiting 1Tegafur 1Surgical Procedures, Operative 1Starch 1Rubidium-82 1Ritonavir 1Quercetin 1Propofol 1Positron Emission Tomography Computed Tomography 1Midazolam 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Luteolin 1Liquid Biopsy 1Indinavir 1Fluorouracil 1Fluorodeoxyglucose F18 1Flavonoids 1Counseling 1Blood Specimen Collection 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Mouth Neoplasms × Quercetin × Clear all
NCT05456022 2022-07-13

Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line

Cairo University

Phase 2 Unknown
1,000,000 enrolled
Head & Neck

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡